Bristol Myers Squibb Co

USPTO Trademark & Patent Filings

Bristol Myers Squibb Co
Trademark Applications
Mark Image

Registration | Serial
Trademark
Application Date
 LONPLEET
"LONPLEET"
77877605
LONPLEET
2009-11-20
 METDICITI
"METDICITI"
77877508
METDICITI
2009-11-20
 EBACITI
"EBACITI"
77877524
EBACITI
2009-11-20
 THAT I CAN DO
"THAT I CAN DO"
77875007
THAT I CAN DO
2009-11-18
 PARSIFAL - PILOT ATAZANAVIR-RALTEGRAVIR SWITCH IN HIV INFECTED SUBJECTS WITH A REDUCTION OF QUALITY OF LIFE
"PARSIFAL - PILOT ATAZANAVIR-RALTEGRAVIR SWITCH IN HIV INFECTED SUBJECTS WITH A REDUCTION OF QUALITY OF LIFE"
77873429
PARSIFAL - PILOT ATAZANAVIR-RALTEGRAVIR SWITCH IN HIV INFECTED SUBJECTS WITH A REDUCTION OF QUALITY OF LIFE
2009-11-16
 ONGLYZA
"ONGLYZA"
77871907
ONGLYZA
2009-11-13
 XCLEEM
"XCLEEM"
77865857
XCLEEM
2009-11-05
 XCLENE
"XCLENE"
77865626
XCLENE
2009-11-05
 XCLEME
"XCLEME"
77865870
XCLEME
2009-11-05
 SOLISTREME
"SOLISTREME"
77865633
SOLISTREME
2009-11-05
 NAVATERN
"NAVATERN"
77865607
NAVATERN
2009-11-05
 XPLEEV
"XPLEEV"
77865884
XPLEEV
2009-11-05
 SOLISTREAM
"SOLISTREAM"
77865642
SOLISTREAM
2009-11-05
 APPEBB
"APPEBB"
77865610
APPEBB
2009-11-05
 XPLEVE
"XPLEVE"
77865895
XPLEVE
2009-11-05
 SOLISTREEM
"SOLISTREEM"
77865655
SOLISTREEM
2009-11-05
 EXCLEEN
"EXCLEEN"
77865616
EXCLEEN
2009-11-05
 QLYMB
"QLYMB"
77865847
QLYMB
2009-11-05
 XCLEEN
"XCLEEN"
77865621
XCLEEN
2009-11-05
 BRAPALO
"BRAPALO"
77864491
BRAPALO
2009-11-04
 BRIPALO
"BRIPALO"
77864490
BRIPALO
2009-11-04
 PLEDGE - PLACEBO VS. ABATACEPT: EFFICACY AND SAFETY STUDY FOR PATIENTS DIAGNOSED WITH SLE
"PLEDGE - PLACEBO VS. ABATACEPT: EFFICACY AND SAFETY STUDY FOR PATIENTS DIAGNOSED WITH SLE"
77863448
PLEDGE - PLACEBO VS. ABATACEPT: EFFICACY AND SAFETY STUDY FOR PATIENTS DIAGNOSED WITH SLE
2009-11-03
 HERALD - HEPATITIS C VIRUS STUDIES: INVESTIGATIONAL MEDICATIONS FOR SUBJECTS WITH CHRONIC INFECTION
"HERALD - HEPATITIS C VIRUS STUDIES: INVESTIGATIONAL MEDICATIONS FOR SUBJECTS WITH CHRONIC INFECTION"
77863452
HERALD - HEPATITIS C VIRUS STUDIES: INVESTIGATIONAL MEDICATIONS FOR SUBJECTS WITH CHRONIC INFECTION
2009-11-03
 HEPCAT - HEPATITIS C INVESTIGATIONAL TRIALS
"HEPCAT - HEPATITIS C INVESTIGATIONAL TRIALS"
77863454
HEPCAT - HEPATITIS C INVESTIGATIONAL TRIALS
2009-11-03
 PLERATRA
"PLERATRA"
77863533
PLERATRA
2009-11-03
 POSITIVE CHARGE
"POSITIVE CHARGE"
4074585 77863547
POSITIVE CHARGE
2009-11-03
 GOBRIVTA
"GOBRIVTA"
77862428
GOBRIVTA
2009-11-02
 ZYFENIB
"ZYFENIB"
77862429
ZYFENIB
2009-11-02
 BRIVAGEF
"BRIVAGEF"
77862433
BRIVAGEF
2009-11-02
 INTERLEVE
"INTERLEVE"
77858971
INTERLEVE
2009-10-28
 XPLEEN
"XPLEEN"
77859033
XPLEEN
2009-10-28
 INTERLENE
"INTERLENE"
77858969
INTERLENE
2009-10-28
 ENTERLENE
"ENTERLENE"
77858970
ENTERLENE
2009-10-28
 KINDULUM
"KINDULUM"
77856063
KINDULUM
2009-10-23
 TOGENSIZ
"TOGENSIZ"
77856081
TOGENSIZ
2009-10-23
 DYNTOTI
"DYNTOTI"
77856066
DYNTOTI
2009-10-23
 TOGENZIS
"TOGENZIS"
77856086
TOGENZIS
2009-10-23
 TOPTIMI
"TOPTIMI"
77856069
TOPTIMI
2009-10-23
 UNRYVILT
"UNRYVILT"
77856055
UNRYVILT
2009-10-23
 TOGENSIS
"TOGENSIS"
77856091
TOGENSIS
2009-10-23
 SURPACIT
"SURPACIT"
77856071
SURPACIT
2009-10-23
 UNRYVLIT
"UNRYVLIT"
77856056
UNRYVLIT
2009-10-23
 SURPAZIG
"SURPAZIG"
77856073
SURPAZIG
2009-10-23
 VUTRANZIT
"VUTRANZIT"
77856060
VUTRANZIT
2009-10-23
 KANVOPI
"KANVOPI"
77856077
KANVOPI
2009-10-23
 EBEYONT
"EBEYONT"
77854680
EBEYONT
2009-10-22
 PRADICITI
"PRADICITI"
77854738
PRADICITI
2009-10-22
 LATAPULT
"LATAPULT"
77854706
LATAPULT
2009-10-22
 EBYOND
"EBYOND"
77854686
EBYOND
2009-10-22
 IMAGNIS
"IMAGNIS"
77854747
IMAGNIS
2009-10-22
 LATAPUL
"LATAPUL"
77854711
LATAPUL
2009-10-22
 EBIOND
"EBIOND"
77854689
EBIOND
2009-10-22
 VATAPULT
"VATAPULT"
77854717
VATAPULT
2009-10-22
 KEYOND
"KEYOND"
77854693
KEYOND
2009-10-22
 OCONQO
"OCONQO"
77854668
OCONQO
2009-10-22
 VATAPUL
"VATAPUL"
77854726
VATAPUL
2009-10-22
 FREPLEET
"FREPLEET"
77854698
FREPLEET
2009-10-22
 LIBNEY
"LIBNEY"
77854675
LIBNEY
2009-10-22
 UTHORITI
"UTHORITI"
77854731
UTHORITI
2009-10-22
 FREPLETE
"FREPLETE"
77854703
FREPLETE
2009-10-22
 PLERETRA
"PLERETRA"
77832063
PLERETRA
2009-09-22
 BANREVLA
"BANREVLA"
77831956
BANREVLA
2009-09-22
 PLERATRO
"PLERATRO"
77832069
PLERATRO
2009-09-22
 IMSYSTREV
"IMSYSTREV"
77832007
IMSYSTREV
2009-09-22
 MASISARC
"MASISARC"
77832109
MASISARC
2009-09-22
 DARCELBA
"DARCELBA"
77832034
DARCELBA
2009-09-22
 IMROBUS
"IMROBUS"
77832041
IMROBUS
2009-09-22
 BELLAQUIP
"BELLAQUIP"
77831903
BELLAQUIP
2009-09-22
 PLORATRO
"PLORATRO"
77832054
PLORATRO
2009-09-22
 REVEPIC
"REVEPIC"
77831949
REVEPIC
2009-09-22
 ERZELBA
"ERZELBA"
77830700
ERZELBA
2009-09-21
 REYATAZ
"REYATAZ"
4415058 77829869
REYATAZ
2009-09-18
 OMNORTA
"OMNORTA"
77826390
OMNORTA
2009-09-15
 BRIDGING CANCER CARE BRISTOL-MYERS SQUIBB FOUNDATION COMMUNITY AWARENESS, PREVENTION AND CARE
"BRIDGING CANCER CARE BRISTOL-MYERS SQUIBB FOUNDATION COMMUNITY AWARENESS, PREVENTION AND CARE"
77818426
BRIDGING CANCER CARE BRISTOL-MYERS SQUIBB FOUNDATION COMMUNITY AWARENESS, PREVENTION AND CARE
2009-09-02
 STAVE - SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS
"STAVE - SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS"
77813061
STAVE - SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS
2009-08-26
 ARZUVAD
"ARZUVAD"
77805792
ARZUVAD
2009-08-17
 TEMBRAV
"TEMBRAV"
77805736
TEMBRAV
2009-08-17
 BRELCAPA
"BRELCAPA"
77805800
BRELCAPA
2009-08-17
 LATRABA
"LATRABA"
77805740
LATRABA
2009-08-17
 ARPIQUA
"ARPIQUA"
77805826
ARPIQUA
2009-08-17
 LATASUV
"LATASUV"
77805749
LATASUV
2009-08-17
 BELTAPTA
"BELTAPTA"
77805831
BELTAPTA
2009-08-17
 TORGLAD
"TORGLAD"
77805756
TORGLAD
2009-08-17
 RENZOPA
"RENZOPA"
77805762
RENZOPA
2009-08-17
 ENGAGE 4 QUALITY HEALTH PATIENTS, PROVIDERS, PAYERS, PARTNERSHIPS
"ENGAGE 4 QUALITY HEALTH PATIENTS, PROVIDERS, PAYERS, PARTNERSHIPS"
77803819
ENGAGE 4 QUALITY HEALTH PATIENTS, PROVIDERS, PAYERS, PARTNERSHIPS
2009-08-13
 STAVE- SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS
"STAVE- SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS"
77802485
STAVE- SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS
2009-08-12
 SAVOR - SAXAGLIPTIN ASSESSMENT OF VASCULAR OUTCOMES RECORDED IN PATIENTS WITH DIABETES MELLITUS
"SAVOR - SAXAGLIPTIN ASSESSMENT OF VASCULAR OUTCOMES RECORDED IN PATIENTS WITH DIABETES MELLITUS"
77802027
SAVOR - SAXAGLIPTIN ASSESSMENT OF VASCULAR OUTCOMES RECORDED IN PATIENTS WITH DIABETES MELLITUS
2009-08-11
 POINT: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY IN MULTIPLE MYELOMA: TANESPIMYCIN
"POINT: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY IN MULTIPLE MYELOMA: TANESPIMYCIN"
77795564
POINT: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY IN MULTIPLE MYELOMA: TANESPIMYCIN
2009-08-03
 TIME-POINT: TANESPIMYCIN IN MYELOMA EVALUATION: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY
"TIME-POINT: TANESPIMYCIN IN MYELOMA EVALUATION: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY"
77795574
TIME-POINT: TANESPIMYCIN IN MYELOMA EVALUATION: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY
2009-08-03
 TOGETHER 4 BETTER HEALTH
"TOGETHER 4 BETTER HEALTH"
77790245
TOGETHER 4 BETTER HEALTH
2009-07-27
 INSUQUEST
"INSUQUEST"
77789903
INSUQUEST
2009-07-27
 GLYPOINT
"GLYPOINT"
77789909
GLYPOINT
2009-07-27
 ORZIPTA
"ORZIPTA"
77789914
ORZIPTA
2009-07-27
 REXPONDA
"REXPONDA"
77789923
REXPONDA
2009-07-27
 EXTENDING AND ENHANCING HUMAN LIFE
"EXTENDING AND ENHANCING HUMAN LIFE"
77789887
EXTENDING AND ENHANCING HUMAN LIFE
2009-07-27
 ENGAGE 4 BETTER HEALTH
"ENGAGE 4 BETTER HEALTH"
77790240
ENGAGE 4 BETTER HEALTH
2009-07-27
 KEXGARD
"KEXGARD"
77789899
KEXGARD
2009-07-27
 SIMPLEGRIP
"SIMPLEGRIP"
77788114
SIMPLEGRIP
2009-07-23
 ERGOGLIDE
"ERGOGLIDE"
77788126
ERGOGLIDE
2009-07-23
 CONFIGLIDE
"CONFIGLIDE"
77782710
CONFIGLIDE
2009-07-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed